Revolution Medicines Inc - Trending symbols
Latest News of Revolution Medicines Inc
Date | Title | Read |
---|---|---|
2025-09-11 20:55 | Revolution Medicines (RVMD) Announces Promising Phase 1 Daraxonrasib Clinical Trial Results | Read |
2025-09-10 23:16 | Revolution Medicines rises on daraxonrasib data that supports phase 3 program | Read |
2025-09-10 22:02 | Revolution Medicines Shares New Clinical Results Supporting Initiation of RASolute 303, a Global Phase 3 Registrational Trial of Daraxonrasib in First Line Metastatic Pancreatic Ductal Adenocarcinoma | Read |
2025-08-19 20:46 | Summit draws Neutral view on risk/reward setup as Piper initiates biotech cancer names | Read |
2025-08-18 19:36 | Revolution Medicines' SWOT analysis: promising cancer drug stock faces pivotal year | Read |
Notifications
Type | Notification | Date |
---|---|---|
RSI Overbought | Overbought RSI (Relative Strength Index) | 2025-09-12 |
Trends
2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Income Tax Expense | -371 | -6,949 | -7,320 | 6,900 | -420 | -3,104 | -3,524 | 4,277 | 753 | |
Accumulated Other Comprehensive Income | -1,780 | 1,224 | -556 | -695 | -1,251 | 380 | -871 | 1,415 | 544 | |
Depreciation and Amortization | 5,077 | -2,544 | 2,533 | -760 | 1,773 | 372 | 2,145 | -8,596 | -6,451 |
Comments
How you think about this?